Long-Acting HIV Antiretroviral Therapy (ART): Cabotegravir/Rilpivirine (CAB/RPV)
This guideline provides recommendations for HIV care teams on implementing long-acting injectable HIV treatment, including cabotegravir and rilpivirine.
This guideline provides recommendations for HIV care teams on implementing long-acting injectable HIV treatment, including cabotegravir and rilpivirine.
This information sheet explains the requirement for insurers to cover Pre-Exposure Prophylaxis (PrEP) without cost-sharing.
This information sheet provides guidance on covering the costs of PrEP (Pre-Exposure Prophylaxis) and PEP (Post-Exposure Prophylaxis).
This journal examines the role of circular RNAs (circRNAs) in HIV-1 replication, highlighting the discovery that backsplicing of the HIV-1 transcript produces multiple circRNAs that enhance viral replication.
This journal presents findings from a pilot randomized clinical trial evaluating two brief interventions aimed at increasing HIV pre-exposure prophylaxis (PrEP) uptake among rural people who inject drugs (PWID) attending syringe services programs (SSPs) in Kentucky.
This fact sheet serves as a conversation guide for patients about how to talk to healthcare providers about TB risk, understand the testing process, and discuss treatment options.
This information sheet offers a concise overview of tuberculosis (TB), detailing its transmission, symptoms, and treatment.
This video addresses the ongoing challenge of tuberculosis (TB) in Alaska, which has the highest TB rate in the United States. It emphasizes that TB can affect anyone and underscores the importance of awareness, testing, and treatment to help end TB in the state.
This fact sheet provides a detailed comparison of tuberculosis (TB) treatment regimens, encompassing both drug-sensitive and drug-resistant TB.
This fact sheet provides basic information on the transmission, symptoms, testing, and treatment of TB.